 | • レポートコード：QFJ1-5158 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、アイゼンメンジャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗不整脈薬、抗凝血剤、エンドセリン受容体拮抗薬、その他）、用途別市場規模（血液検査、心電図（ECG）、胸部X線、心エコー検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、心臓カテーテル検査、歩行検査）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アイゼンメンジャー症候群治療の市場動向 ・企業の競争状況、市場シェア ・アイゼンメンジャー症候群治療の種類別市場規模と予測2016-2027（抗不整脈薬、抗凝血剤、エンドセリン受容体拮抗薬、その他） ・アイゼンメンジャー症候群治療の用途別市場規模と予測2016-2027（血液検査、心電図（ECG）、胸部X線、心エコー検査、コンピューター断層撮影（CT）スキャン、磁気共鳴画像（MRI）、心臓カテーテル検査、歩行検査） ・アイゼンメンジャー症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・アイゼンメンジャー症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アイゼンメンジャー症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アイゼンメンジャー症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・アイゼンメンジャー症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Actelion Pharmaceuticals Ltd.、Gilead Sciences, Inc.、Pfizer, Inc.、Teva Pharmaceutical Industries Ltd.、AstraZeneca plc.、Novartis AG、Merck & Co., Inc.、GlaxoSmithKline plc.、Mylan N.V.、Bayer AG） ・結論 |
The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger syndrome is caused due to a birth defect. The disease is characterized by high blood pressure and abnormal blood flow through the heart. The specific symptoms of Eisenmenger syndrome vary greatly from person to person. The most notable symptom is called cyanosis, which is the bluish discoloration of the skin and mucous membranes. Eisenmenger syndrome is caused by a defect in the structure of the heart, more specifically a ventricular septal defect (VSD) or other shunt. Eisenmenger syndrome belongs to a group of conditions called pulmonary arterial hypertension-PAH.
Market Analysis and Insights: Global Eisenmenger Syndrome Treatment Market
The global Eisenmenger Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eisenmenger Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eisenmenger Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eisenmenger Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eisenmenger Syndrome Treatment market.
Global Eisenmenger Syndrome Treatment Scope and Market Size
Eisenmenger Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eisenmenger Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antiarrhythmic Agents
Blood Thinning Agents
Endothelin Receptor Antagonist
Others
Segment by Application
Blood tests
Electrocardiogram (ECG)
Chest X-ray
Echocardiogram
Computerized tomography (CT) scan
Magnetic resonance imaging (MRI)
Cardiac catheterization
Walking test
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Actelion Pharmaceuticals Ltd.
Gilead Sciences, Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
AstraZeneca plc.
Novartis AG
Merck & Co., Inc.
GlaxoSmithKline plc.
Mylan N.V.
Bayer AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eisenmenger Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antiarrhythmic Agents
1.2.3 Blood Thinning Agents
1.2.4 Endothelin Receptor Antagonist
1.2.5 Others
1.3 Market by Application
1.3.1 Global Eisenmenger Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood tests
1.3.3 Electrocardiogram (ECG)
1.3.4 Chest X-ray
1.3.5 Echocardiogram
1.3.6 Computerized tomography (CT) scan
1.3.7 Magnetic resonance imaging (MRI)
1.3.8 Cardiac catheterization
1.3.9 Walking test
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Eisenmenger Syndrome Treatment Market Perspective (2016-2027)
2.2 Eisenmenger Syndrome Treatment Growth Trends by Regions
2.2.1 Eisenmenger Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eisenmenger Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Eisenmenger Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Eisenmenger Syndrome Treatment Industry Dynamic
2.3.1 Eisenmenger Syndrome Treatment Market Trends
2.3.2 Eisenmenger Syndrome Treatment Market Drivers
2.3.3 Eisenmenger Syndrome Treatment Market Challenges
2.3.4 Eisenmenger Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eisenmenger Syndrome Treatment Players by Revenue
3.1.1 Global Top Eisenmenger Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Eisenmenger Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Eisenmenger Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Eisenmenger Syndrome Treatment Revenue
3.4 Global Eisenmenger Syndrome Treatment Market Concentration Ratio
3.4.1 Global Eisenmenger Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eisenmenger Syndrome Treatment Revenue in 2020
3.5 Eisenmenger Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Eisenmenger Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Eisenmenger Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eisenmenger Syndrome Treatment Breakdown Data by Type
4.1 Global Eisenmenger Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Eisenmenger Syndrome Treatment Forecasted Market Size by Type (2022-2027)
5 Eisenmenger Syndrome Treatment Breakdown Data by Application
5.1 Global Eisenmenger Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Eisenmenger Syndrome Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Eisenmenger Syndrome Treatment Market Size (2016-2027)
6.2 North America Eisenmenger Syndrome Treatment Market Size by Type
6.2.1 North America Eisenmenger Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Eisenmenger Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Eisenmenger Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Eisenmenger Syndrome Treatment Market Size by Application
6.3.1 North America Eisenmenger Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Eisenmenger Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Eisenmenger Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Eisenmenger Syndrome Treatment Market Size by Country
6.4.1 North America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Eisenmenger Syndrome Treatment Market Size (2016-2027)
7.2 Europe Eisenmenger Syndrome Treatment Market Size by Type
7.2.1 Europe Eisenmenger Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Eisenmenger Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Eisenmenger Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Eisenmenger Syndrome Treatment Market Size by Application
7.3.1 Europe Eisenmenger Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Eisenmenger Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Eisenmenger Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Eisenmenger Syndrome Treatment Market Size by Country
7.4.1 Europe Eisenmenger Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Eisenmenger Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Eisenmenger Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Eisenmenger Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Eisenmenger Syndrome Treatment Market Size by Type
9.2.1 Latin America Eisenmenger Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Eisenmenger Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Eisenmenger Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Eisenmenger Syndrome Treatment Market Size by Application
9.3.1 Latin America Eisenmenger Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Eisenmenger Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Eisenmenger Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Eisenmenger Syndrome Treatment Market Size by Country
9.4.1 Latin America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eisenmenger Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Actelion Pharmaceuticals Ltd.
11.1.1 Actelion Pharmaceuticals Ltd. Company Details
11.1.2 Actelion Pharmaceuticals Ltd. Business Overview
11.1.3 Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Introduction
11.1.4 Actelion Pharmaceuticals Ltd. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.1.5 Actelion Pharmaceuticals Ltd. Recent Development
11.2 Gilead Sciences, Inc.
11.2.1 Gilead Sciences, Inc. Company Details
11.2.2 Gilead Sciences, Inc. Business Overview
11.2.3 Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Introduction
11.2.4 Gilead Sciences, Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.2.5 Gilead Sciences, Inc. Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Eisenmenger Syndrome Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.3.5 Pfizer, Inc. Recent Development
11.4 Teva Pharmaceutical Industries Ltd.
11.4.1 Teva Pharmaceutical Industries Ltd. Company Details
11.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.4.3 Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Introduction
11.4.4 Teva Pharmaceutical Industries Ltd. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.5 AstraZeneca plc.
11.5.1 AstraZeneca plc. Company Details
11.5.2 AstraZeneca plc. Business Overview
11.5.3 AstraZeneca plc. Eisenmenger Syndrome Treatment Introduction
11.5.4 AstraZeneca plc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.5.5 AstraZeneca plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Eisenmenger Syndrome Treatment Introduction
11.6.4 Novartis AG Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Company Details
11.7.2 Merck & Co., Inc. Business Overview
11.7.3 Merck & Co., Inc. Eisenmenger Syndrome Treatment Introduction
11.7.4 Merck & Co., Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.7.5 Merck & Co., Inc. Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Eisenmenger Syndrome Treatment Introduction
11.9.4 Mylan N.V. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.9.5 Mylan N.V. Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Eisenmenger Syndrome Treatment Introduction
11.10.4 Bayer AG Revenue in Eisenmenger Syndrome Treatment Business (2016-2021)
11.10.5 Bayer AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Eisenmenger Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antiarrhythmic Agents
Table 3. Key Players of Blood Thinning Agents
Table 4. Key Players of Endothelin Receptor Antagonist
Table 5. Key Players of Others
Table 6. Global Eisenmenger Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Eisenmenger Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Eisenmenger Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Eisenmenger Syndrome Treatment Market Share by Regions (2016-2021)
Table 10. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Eisenmenger Syndrome Treatment Market Share by Regions (2022-2027)
Table 12. Eisenmenger Syndrome Treatment Market Trends
Table 13. Eisenmenger Syndrome Treatment Market Drivers
Table 14. Eisenmenger Syndrome Treatment Market Challenges
Table 15. Eisenmenger Syndrome Treatment Market Restraints
Table 16. Global Eisenmenger Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Eisenmenger Syndrome Treatment Market Share by Players (2016-2021)
Table 18. Global Top Eisenmenger Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eisenmenger Syndrome Treatment as of 2020)
Table 19. Ranking of Global Top Eisenmenger Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Eisenmenger Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Eisenmenger Syndrome Treatment Product Solution and Service
Table 23. Date of Enter into Eisenmenger Syndrome Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Eisenmenger Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Eisenmenger Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Eisenmenger Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Eisenmenger Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Eisenmenger Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Eisenmenger Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Eisenmenger Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Eisenmenger Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Eisenmenger Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Eisenmenger Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Eisenmenger Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Eisenmenger Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Eisenmenger Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Eisenmenger Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Actelion Pharmaceuticals Ltd. Company Details
Table 64. Actelion Pharmaceuticals Ltd. Business Overview
Table 65. Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Product
Table 66. Actelion Pharmaceuticals Ltd. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 67. Actelion Pharmaceuticals Ltd. Recent Development
Table 68. Gilead Sciences, Inc. Company Details
Table 69. Gilead Sciences, Inc. Business Overview
Table 70. Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Product
Table 71. Gilead Sciences, Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 72. Gilead Sciences, Inc. Recent Development
Table 73. Pfizer, Inc. Company Details
Table 74. Pfizer, Inc. Business Overview
Table 75. Pfizer, Inc. Eisenmenger Syndrome Treatment Product
Table 76. Pfizer, Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer, Inc. Recent Development
Table 78. Teva Pharmaceutical Industries Ltd. Company Details
Table 79. Teva Pharmaceutical Industries Ltd. Business Overview
Table 80. Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Product
Table 81. Teva Pharmaceutical Industries Ltd. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 82. Teva Pharmaceutical Industries Ltd. Recent Development
Table 83. AstraZeneca plc. Company Details
Table 84. AstraZeneca plc. Business Overview
Table 85. AstraZeneca plc. Eisenmenger Syndrome Treatment Product
Table 86. AstraZeneca plc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 87. AstraZeneca plc. Recent Development
Table 88. Novartis AG Company Details
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Eisenmenger Syndrome Treatment Product
Table 91. Novartis AG Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 92. Novartis AG Recent Development
Table 93. Merck & Co., Inc. Company Details
Table 94. Merck & Co., Inc. Business Overview
Table 95. Merck & Co., Inc. Eisenmenger Syndrome Treatment Product
Table 96. Merck & Co., Inc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 97. Merck & Co., Inc. Recent Development
Table 98. GlaxoSmithKline plc. Company Details
Table 99. GlaxoSmithKline plc. Business Overview
Table 100. GlaxoSmithKline plc. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 101. GlaxoSmithKline plc. Recent Development
Table 102. Mylan N.V. Company Details
Table 103. Mylan N.V. Business Overview
Table 104. Mylan N.V. Eisenmenger Syndrome Treatment Product
Table 105. Mylan N.V. Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 106. Mylan N.V. Recent Development
Table 107. Bayer AG Company Details
Table 108. Bayer AG Business Overview
Table 109. Bayer AG Eisenmenger Syndrome Treatment Product
Table 110. Bayer AG Revenue in Eisenmenger Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 111. Bayer AG Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eisenmenger Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antiarrhythmic Agents Features
Figure 3. Blood Thinning Agents Features
Figure 4. Endothelin Receptor Antagonist Features
Figure 5. Others Features
Figure 6. Global Eisenmenger Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 7. Blood tests Case Studies
Figure 8. Electrocardiogram (ECG) Case Studies
Figure 9. Chest X-ray Case Studies
Figure 10. Echocardiogram Case Studies
Figure 11. Computerized tomography (CT) scan Case Studies
Figure 12. Magnetic resonance imaging (MRI) Case Studies
Figure 13. Cardiac catheterization Case Studies
Figure 14. Walking test Case Studies
Figure 15. Eisenmenger Syndrome Treatment Report Years Considered
Figure 16. Global Eisenmenger Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Eisenmenger Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Eisenmenger Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Eisenmenger Syndrome Treatment Market Share by Regions (2022-2027)
Figure 20. Global Eisenmenger Syndrome Treatment Market Share by Players in 2020
Figure 21. Global Top Eisenmenger Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eisenmenger Syndrome Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Eisenmenger Syndrome Treatment Revenue in 2020
Figure 23. Global Eisenmenger Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Eisenmenger Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Eisenmenger Syndrome Treatment Market Share by Type (2016-2027)
Figure 27. North America Eisenmenger Syndrome Treatment Market Share by Application (2016-2027)
Figure 28. North America Eisenmenger Syndrome Treatment Market Share by Country (2016-2027)
Figure 29. United States Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Eisenmenger Syndrome Treatment Market Share by Type (2016-2027)
Figure 33. Europe Eisenmenger Syndrome Treatment Market Share by Application (2016-2027)
Figure 34. Europe Eisenmenger Syndrome Treatment Market Share by Country (2016-2027)
Figure 35. Germany Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Region (2016-2027)
Figure 45. China Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Eisenmenger Syndrome Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Eisenmenger Syndrome Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Eisenmenger Syndrome Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Eisenmenger Syndrome Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Eisenmenger Syndrome Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Eisenmenger Syndrome Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Eisenmenger Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 65. Gilead Sciences, Inc. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 66. Pfizer, Inc. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 68. AstraZeneca plc. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 70. Merck & Co., Inc. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 71. GlaxoSmithKline plc. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 72. Mylan N.V. Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 73. Bayer AG Revenue Growth Rate in Eisenmenger Syndrome Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のレット症候群治療市場規模・現状・予測（2021年-2027年） Rett Syndrome is a non-neurological degenerative disease that seriously affects children's psychomotor development. Market Analysis and Insights: Global Rett Syndrome Treatment Market The global Rett Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in …- 世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…
- 世界のアルポート症候群治療市場規模・現状・予測（2021年-2027年） Alport Syndrome is the hereditary genetic disorder characterized by glomerulonephritis, abnormal vision, acute hearing loss and end-stage renal disease. Alport Syndrome is also called the hereditary nephritis. Market Analysis and Insights: Global Alport Syndrome Treatment Market The global Alport Sy…
- 世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
- 世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…